IS5788A - Lyfjafræðileg notkun á NAB1 og NAB2 - Google Patents

Lyfjafræðileg notkun á NAB1 og NAB2

Info

Publication number
IS5788A
IS5788A IS5788A IS5788A IS5788A IS 5788 A IS5788 A IS 5788A IS 5788 A IS5788 A IS 5788A IS 5788 A IS5788 A IS 5788A IS 5788 A IS5788 A IS 5788A
Authority
IS
Iceland
Prior art keywords
nab1
nab2
pharmacological use
pharmacological
Prior art date
Application number
IS5788A
Other languages
English (en)
Inventor
Braddock Martin
Jeffrey Campbell Callum
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9814989.1A external-priority patent/GB9814989D0/en
Priority claimed from GBGB9819826.0A external-priority patent/GB9819826D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS5788A publication Critical patent/IS5788A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS5788A 1998-07-11 2000-12-22 Lyfjafræðileg notkun á NAB1 og NAB2 IS5788A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9814989.1A GB9814989D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819826.0A GB9819826D0 (en) 1998-09-12 1998-09-12 Gene therapy method
PCT/GB1999/002199 WO2000003014A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2

Publications (1)

Publication Number Publication Date
IS5788A true IS5788A (is) 2000-12-22

Family

ID=26314007

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5788A IS5788A (is) 1998-07-11 2000-12-22 Lyfjafræðileg notkun á NAB1 og NAB2

Country Status (22)

Country Link
EP (1) EP1097200A1 (is)
JP (1) JP2002520020A (is)
KR (1) KR20010071832A (is)
CN (1) CN1317045A (is)
AP (1) AP2001002038A0 (is)
AU (1) AU763713B2 (is)
BR (1) BR9912018A (is)
CA (1) CA2336805A1 (is)
EA (1) EA200100028A1 (is)
EE (1) EE200100020A (is)
HR (1) HRP20010025A2 (is)
HU (1) HUP0102835A3 (is)
ID (1) ID27742A (is)
IL (1) IL140533A0 (is)
IS (1) IS5788A (is)
NO (1) NO20010166L (is)
NZ (1) NZ509174A (is)
PL (1) PL345507A1 (is)
SK (1) SK382001A3 (is)
TR (1) TR200100622T2 (is)
WO (1) WO2000003014A1 (is)
YU (1) YU1901A (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
AU2001291019A1 (en) 2000-09-15 2002-03-26 Genvec, Inc. Method of modulating neovascularization
WO2004083435A1 (en) * 2003-03-17 2004-09-30 Julius-Maximilians-Uni Versität Würzburg Nab proteins and their use in diagnostic and therapeutic applications in heart disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5697901A (en) * 1989-12-14 1997-12-16 Elof Eriksson Gene delivery by microneedle injection

Also Published As

Publication number Publication date
AP2001002038A0 (en) 2001-03-31
TR200100622T2 (tr) 2001-10-22
EE200100020A (et) 2002-06-17
CA2336805A1 (en) 2000-01-20
BR9912018A (pt) 2006-01-31
AU763713B2 (en) 2003-07-31
EP1097200A1 (en) 2001-05-09
AU4791499A (en) 2000-02-01
NO20010166L (no) 2001-03-06
YU1901A (sh) 2005-06-10
HRP20010025A2 (en) 2001-12-31
NO20010166D0 (no) 2001-01-10
IL140533A0 (en) 2002-02-10
HUP0102835A2 (hu) 2001-11-28
SK382001A3 (en) 2001-09-11
NZ509174A (en) 2003-08-29
HUP0102835A3 (en) 2003-09-29
CN1317045A (zh) 2001-10-10
PL345507A1 (en) 2001-12-17
WO2000003014A1 (en) 2000-01-20
ID27742A (id) 2001-04-26
KR20010071832A (ko) 2001-07-31
EA200100028A1 (ru) 2001-08-27
JP2002520020A (ja) 2002-07-09

Similar Documents

Publication Publication Date Title
NO20000852D0 (no) Skrueseparator
NO991151D0 (no) Forbindelse og anvendelse derav
DE69620260D1 (de) Freistehender innenisolationskörper
DK0937280T3 (da) Multifunktionelle mikrostrukturer og fremstilling deraf
NO992199D0 (no) Gjenget forbindelse
FI973415A7 (fi) Kannettavat elektroniset laitteet
DE59802830D1 (de) Orthesengelenk
NO984536D0 (no) Skruforbindelse
DE69816701D1 (de) Wendelantenne
BR9706700A (pt) Relógio eletrônico combinado
ATA151697A (de) Winkelstabile schraubenverbindung
DE59808490D1 (de) Penisextensionsgerät
DK1398011T3 (da) Stomianordninger
DK0853933T3 (da) Ostomikobling
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DE69931296D1 (de) Kanalwählendes Gerät
FR2767494B1 (fr) Spiraleuse
IS5788A (is) Lyfjafræðileg notkun á NAB1 og NAB2
DE69831998D1 (de) Elektronisches Uhrwerk
IS5636A (is) Meðhöndlun á ofsahræðslu köstum
KR960030447U (ko) 혈압계용 손목 압박대
NO20010470D0 (no) Koplingsinnretning og anvendelse av samme
DE69812105D1 (de) Einnahmevorrichtungen
DE69908589D1 (de) Entfernte rechnerbearbeitung